- Home
- CTSO vs CLST Comparison
CTSO vs CLST Comparison
Compare CTSO & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- CLST
- Stock Information
- Founded
- CTSO 1997
- CLST 1922
- Country
- CTSO United States
- CLST United States
- Employees
- CTSO N/A
- CLST N/A
- Industry
- CTSO Medical/Dental Instruments
- CLST
- Sector
- CTSO Health Care
- CLST
- Exchange
- CTSO Nasdaq
- CLST Nasdaq
- Market Cap
- CTSO 57.2M
- CLST 50.2M
- IPO Year
- CTSO N/A
- CLST N/A
- Fundamental
- Price
- CTSO $0.98
- CLST $11.55
- Analyst Decision
- CTSO Strong Buy
- CLST
- Analyst Count
- CTSO 3
- CLST 0
- Target Price
- CTSO $4.67
- CLST N/A
- AVG Volume (30 Days)
- CTSO 147.2K
- CLST 6.6K
- Earning Date
- CTSO 11-07-2024
- CLST 10-24-2024
- Dividend Yield
- CTSO N/A
- CLST N/A
- EPS Growth
- CTSO N/A
- CLST N/A
- EPS
- CTSO N/A
- CLST N/A
- Revenue
- CTSO $37,739,531.00
- CLST $4,949,000.00
- Revenue This Year
- CTSO $13.09
- CLST N/A
- Revenue Next Year
- CTSO $15.68
- CLST N/A
- P/E Ratio
- CTSO N/A
- CLST N/A
- Revenue Growth
- CTSO 1.80
- CLST N/A
- 52 Week Low
- CTSO $0.70
- CLST $10.60
- 52 Week High
- CTSO $2.15
- CLST $12.10
- Technical
- Relative Strength Index (RSI)
- CTSO 44.01
- CLST 54.56
- Support Level
- CTSO $0.71
- CLST $11.37
- Resistance Level
- CTSO $0.99
- CLST $11.71
- Average True Range (ATR)
- CTSO 0.09
- CLST 0.10
- MACD
- CTSO 0.00
- CLST 0.01
- Stochastic Oscillator
- CTSO 59.97
- CLST 63.64
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.